Advertisement
Screener

EyePoint, Inc. (EYPT) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.5 / 5 stars · 47/94 Roast Me

EyePoint, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

EyePoint, Inc. (EYPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2018-05-10

  • EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2016-09-30 was 0.00%.
  • EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2015-09-30 was 0.00%.
  • EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2014-09-30 was 0.00%.
  • EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2013-09-30 was 0.00%.
  • EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2016 was 0.00%.
  • EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2015 was 0.00%.
  • EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2014 was 0.00%.
  • EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2013 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend RateShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2018-03-310.00%
10-Q · filed 2018-05-10
2018-03-280.00%
10-Q · filed 2018-05-10
2016-09-300.00%
10-Q · filed 2016-11-08
2016-06-300.00%
10-K · filed 2016-09-13
2016-03-310.00%
10-Q · filed 2016-05-06
2015-12-310.00%
10-Q · filed 2016-02-09
2015-09-300.00%
10-Q · filed 2015-11-06
2015-06-300.00%
10-K · filed 2016-09-13
2015-03-310.00%
10-Q · filed 2015-05-08
2014-12-310.00%
10-Q · filed 2015-02-06
2014-09-300.00%
10-Q · filed 2014-11-07
2014-06-300.00%
10-K · filed 2016-09-13
2014-03-310.00%
10-Q · filed 2014-05-14
2013-12-310.00%
10-Q · filed 2014-02-12
2013-09-300.00%
10-Q · filed 2013-11-13
2013-06-300.00%
10-K · filed 2015-09-10
2012-06-300.00%
10-K · filed 2014-09-11
2011-06-300.00%
10-K · filed 2013-09-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15